Hypertrophic cardiomyopathy (HCM) is a genetic heart disease that causes thickening of the walls of the heart’s left ventricle. This can make it more difficult for the heart to pump blood throughout ...
SOUTH SAN FRANCISCO, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the launch of EARTH-HCM (Epidemiology, Awareness, Real-world Treatment and ...
The FDA has approved the drug Camzyos to treat obstructive hypertrophic cardiomyopathy (HCM). A second drug is currently under review. Other medications and lifestyle strategies can also help manage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback